FREMONT, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM” or the “Company”) (NASDAQ:ACMR), a leading supplier of wafer cleaning technologies for advanced semiconductor devices, today reported financial results for its third fiscal quarter ended September 30, 2021.
ACM’s President and Chief Executive Officer Dr. David Wang commented, “We delivered impressive third quarter results, with record revenue and shipments. Our results demonstrate the effectiveness of ACM’s multi-product strategy, with solid growth from our flagship cleaning tools, and increased contribution from both electrochemical planting (ECP) and advanced packaging products. We are making great progress with major semiconductor manufacturers, with evaluation tool orders from three new potential customers. Despite industry-wide capacity constraints, our business momentum continues, and we have narrowed the range of our 2021 outlook accordingly.”
Dr. Wang continued, “We are excited that our subsidiary ACM Research (Shanghai), Inc. expects to be soon listed on the STAR Market. We remain confident that a successful STAR Market listing, combined with the listing of ACM’s Class A common stock on the Nasdaq Global Market, will provide a strong foundation to accelerate our mission to become a global player in the semiconductor equipment industry.”
Three Months Ended September 30, | ||||||||||||||||
GAAP | Non-GAAP(1) | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
(dollars in thousands, except per share data) | ||||||||||||||||
Revenue | $ | 67,013 | $ | 47,665 | $ | 67,013 | $ | 47,665 | ||||||||
Gross margin | 44.3 | % | 42.7 | % | 44.5 | % | 42.8 | % | ||||||||
Income from operations | $ | 11,795 | $ | 7,506 | $ | 13,073 | $ | 10,285 | ||||||||
Net income attributable to ACM Research, Inc. | $ | 10,155 | $ | 8,627 | $ | 12,352 | $ | 8,969 | ||||||||
Basic EPS | $ | 0.52 | $ | 0.47 | $ | 0.64 | $ | 0.49 | ||||||||
Diluted EPS | $ | 0.46 | $ | 0.40 | $ | 0.56 | $ | 0.42 |
Nine Months Ended September 30, | ||||||||||||||||
GAAP | Non-GAAP(1) | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
(dollars in thousands, except per share data) | ||||||||||||||||
Revenue | $ | 164,609 | $ | 111,062 | $ | 164,609 | $ | 111,062 | ||||||||
Gross margin | 42.2 | % | 45.0 | % | 42.3 | % | 45.1 | % | ||||||||
Income from operations | $ | 19,576 | $ | 16,060 | $ | 23,399 | $ | 20,383 | ||||||||
Net income attributable to ACM Research, Inc. | $ | 22,192 | $ | 10,251 | $ | 24,198 | $ | 17,568 | ||||||||
Basic EPS | $ | 1.16 | $ | 0.57 | $ | 1.27 | $ | 0.97 | ||||||||
Diluted EPS | $ | 1.02 | $ | 0.48 | $ | 1.11 | $ | 0.83 |
(1) Reconciliations to U.S. generally accepted accounting principles (GAAP) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to Non-GAAP Financial Measures.” Non-GAAP financial measures exclude stock-based compensation, and non-GAAP net income attributable to ACM Research, Inc. and basic and diluted EPS also exclude non-cash changes in fair value of financial assets and liabilities and unrealized gain (loss) on trading securities.
Outlook
For fiscal year 2021, the Company now expects revenue to be in the range of $230 million to $240 million, versus the previous guidance range of $225 million to $240 million. This expectation assumes, among other factors, stability with respect to the global COVID-19 pandemic and stability in US-China trade policy. The range of ACM’s 2021 outlook reflects, among other things, variances in spending scenarios for the production ramps of key customers, management of ACM’s supply chain, and the timing of acceptances for first tools under evaluation in the field.
Third Quarter Operating Highlights and Recent Announcements
Financial Summary
Unless otherwise noted, the following figures refer to the third quarter of 2021 and comparisons are with the third quarter of 2020.
Conference Call Details
A conference call to discuss results will be held on Friday, November 5, 2021, at 8:00 a.m. Eastern Time (8:00 p.m.China Time). Dial-in details for the call are as follows. Please reference conference ID 8233909.
Phone Number | Toll-Free Number | |||
United States | +1 (661) 567-1217 | +1 (833) 562-0137 | ||
Hong Kong | +852 5819 4851 | +852 8009 66253 | ||
Mainland China | +86 8008700169 | |||
+86 4006828609 |
A recording of the webcast will be available on the investor page of the ACM website at www.acmrcsh.com for one week following the call.
Use of Non-GAAP Financial Measures
ACM presents non-GAAP gross margin, operating expenses, operating income, net income (loss) attributable to ACM Research, Inc., and basic and diluted earnings per share as supplemental measures to GAAP financial measures regarding ACM’s operational performance. These supplemental measures exclude the impact of stock-based compensation, which ACM does not believe is indicative of its core operating results. In addition, non-GAAP net income attributable to ACM Research, Inc. and basic and diluted EPS exclude non-cash change in fair value of financial assets and liabilities and unrealized gain on trading securities, which ACM also believes are not indicative of its core operating results. A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure is provided below under “Reconciliation of Non-GAAP to GAAP Financial Measures.”
ACM believes these non-GAAP financial measures are useful to investors in assessing its operating performance. ACM uses these financial measures internally to evaluate its operating performance and for planning and forecasting of future periods. Financial analysts may focus on and publish both historical results and future projections based on the non-GAAP financial measures. ACM also believes it is in the best interests of investors for ACM to provide this non-GAAP information.
While ACM believes these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of these non-GAAP financial measures. These non-GAAP financial measures may not be reported by competitors, and they may not be directly comparable to similarly titled measures of other companies due to differences in calculation methodologies. The non-GAAP financial measures are not an alternative to GAAP information and are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures. They should be used only as a supplement to GAAP information and should be considered only in conjunction with ACM’s consolidated financial statements prepared in accordance with GAAP.
Forward-Looking Statements
Certain statements contained in the second and third paragraphs of this press release, under the heading “Outlook” above, and in the second, third, fourth and sixth bullets under “Third Quarter Operating Highlights and Recent Announcements” above are not historical facts and may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding the intent, belief and current expectations with respect to: the demand for ACM’s tools; the timing and ability of ACM to secure orders from, and deliver tools to, new customers; and ACM’s plans for completion of the STAR Market initial public offering of shares of ACM Shanghai, which are expectations only, reflect management's current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, the following, any of which could be exacerbated even further by the continuing COVID-19 outbreak in China and globally; anticipated customer orders or identified market opportunities may not grow or develop as anticipated; customer orders already received may be postponed or canceled; ACM may be unable to obtain the qualification and acceptance of its delivered tools when anticipated or at all, which would delay or preclude ACM’s recognition of revenue from the sale of those tools; suppliers may not be able to meet ACM’s demands on a timely basis; ACM’s technologies and tools may not gain market acceptance; ACM may be unable to compete effectively by, among other things, enhancing its existing tools, adding additional production capacity and engaging additional major customers; volatile global economic, market, industry and other conditions could result in sharply lower demand for products containing semiconductors and for the Company's products and in disruption of capital and credit markets; trade regulations, currency fluctuations, political instability and war may materially adversely affect ACM due to its substantial non-U.S. customer and supplier base and its substantial non-U.S. manufacturing operations. ACM Shanghai may not be able to complete its IPO and listing on the expected terms or within the expected time frame, if at all, for a number of reasons, many of which are outside ACM Shanghai’s control. Among other factors, the IPO is subject to closing conditions typical for initial public offerings on the STAR Market. ACM cannot guarantee any future results, levels of activity, performance or achievements. ACM undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in its expectations regarding these forward-looking statements or the occurrence of unanticipated events.
About ACM Research, Inc.
ACM develops, manufactures, and sells semiconductor process equipment for single-wafer or batch wet cleaning, electroplating, stress-free polishing and thermal processes that are critical to advanced semiconductor device manufacturing, as well as wafer-level packaging. The Company is committed to delivering customized, high performance, cost-effective process solutions that semiconductor manufacturers can use in numerous manufacturing steps to improve productivity and product yield.
© ACM Research, Inc. SAPS, ULTRA C, ULTRA C SAPS, and the ACM Research logo are trademarks of ACM Research, Inc. For convenience, this trademark appears in this press release without a ™ symbol, but that practice does not mean that ACM Research, Inc. will not assert, to the fullest extent under applicable law, its rights to the trademarks.
For investor and media inquiries, please contact:
In the United States: | The Blueshirt GroupRalph Fong+1 (415) 489-2195ralph@blueshirtgroup.com | |
In China: | The Blueshirt Group Asia Gary Dvorchak, CFA +86 (138) 1079-1480 gary@blueshirtgroup.com | |
ACM RESEARCH, INC. | |||||||
Condensed Consolidated Balance Sheets | |||||||
September 30, 2021 | December 31, 2020 | ||||||
(Unaudited) | |||||||
(In thousands, except share and per share data) | |||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 65,036 | $ | 71,766 | |||
Trading securities | 30,219 | 28,239 | |||||
Accounts receivable, less allowance for doubtful accounts of $0 as of September 30, 2021 and December 31, 2020 | 84,787 | 56,441 | |||||
Other receivables | 13,165 | 9,679 | |||||
Inventories | 176,609 | 88,639 | |||||
Prepaid expenses | 7,531 | 5,892 | |||||
Total current assets | 377,347 | 260,656 | |||||
Property, plant and equipment, net | 10,005 | 8,192 | |||||
Land use right, net | 9,556 | 9,646 | |||||
Operating lease right-of-use assets, net | 4,599 | 4,297 | |||||
Intangible assets, net | 556 | 554 | |||||
Deferred tax assets | 15,795 | 11,076 | |||||
Long-term investments | 7,408 | 6,340 | |||||
Other long-term assets | 44,243 | 40,496 | |||||
Total assets | 469,509 | 341,257 | |||||
Liabilities and Stockholders’ Equity | |||||||
Current liabilities: | |||||||
Short-term borrowings | 15,201 | 26,147 | |||||
Current portion of long-term borrowings | 2,351 | 1,591 | |||||
Accounts payable | 92,825 | 35,603 | |||||
Advances from customers | 52,681 | 17,888 | |||||
Deferred revenue | 2,403 | 1,343 | |||||
Income taxes payable | 1,233 | 31 | |||||
FIN-48 payable | 83 | 83 | |||||
Other payables and accrued expenses | 25,950 | 18,805 | |||||
Current portion of operating lease liability | 2,480 | 1,417 | |||||
Total current liabilities | 195,207 | 102,908 | |||||
Long-term borrowings | 23,080 | 17,979 | |||||
Long-term operating lease liability | 2,119 | 2,880 | |||||
Deferred tax liability | 1,293 | 1,286 | |||||
Other long-term liabilities | 5,303 | 8,034 | |||||
Total liabilities | 227,002 | 133,087 | |||||
Commitments and contingencies | |||||||
Stockholders’ equity: | |||||||
Common stock – Class A, par value $0.0001: 150,000,000 shares authorized as of September 30, 2021 and 50,000,000 shares authorized as of December 31, 2020; 17,798,740 shares issued and outstanding as of September 30, 2021 and 16,896,693 shares issued and outstanding as of December 31, 2020 | 2 | 2 | |||||
Common stock–Class B, par value $0.0001: 5,307,816 shares authorized as of September 30, 2021 and 2,409,738 shares authorized as of December 31, 2020; 1,707,605 shares issued and outstanding as of September 30, 2021 and 1,802,606 shares issued and outstanding as of December 31, 2020 | - | - | |||||
Additional paid in capital | 110,776 | 102,004 | |||||
Accumulated surplus | 56,479 | 34,287 | |||||
Accumulated other comprehensive income | 5,759 | 4,857 | |||||
Total ACM Research, Inc. stockholders’ equity | 173,016 | 141,150 | |||||
Non-controlling interests | 69,491 | 67,020 | |||||
Total stockholders’ equity | 242,507 | 208,170 | |||||
Total liabilities and stockholders’ equity | $ | 469,509 | $ | 341,257 | |||
ACM RESEARCH, INC. | |||||||||||||||
Condensed Consolidated Statements of Operations and Comprehensive Income | |||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||
(Unaudited) | (Unaudited) | ||||||||||||||
( In thousands, except share and per share data) | ( In thousands, except share and per share data) | ||||||||||||||
Revenue | $ | 67,013 | $ | 47,665 | $ | 164,609 | $ | 111,062 | |||||||
Cost of revenue | 37,328 | 27,324 | 95,199 | 61,137 | |||||||||||
Gross profit | 29,685 | 20,341 | 69,410 | 49,925 | |||||||||||
Operating expenses: | |||||||||||||||
Sales and marketing | 6,363 | 3,924 | 17,460 | 11,524 | |||||||||||
Research and development | 7,856 | 4,343 | 21,293 | 13,241 | |||||||||||
General and administrative | 3,671 | 4,568 | 11,081 | 9,100 | |||||||||||
Total operating expenses, net | 17,890 | 12,835 | 49,834 | 33,865 | |||||||||||
Income from operations | 11,795 | 7,506 | 19,576 | 16,060 | |||||||||||
Interest income | 33 | 179 | 113 | 834 | |||||||||||
Interest expense | (191 | ) | (272 | ) | (574 | ) | (611 | ) | |||||||
Change in fair value of financial liability | - | (6,533 | ) | - | (11,964 | ) | |||||||||
Unrealized gain (loss) on trading securities | (919 | ) | 8,970 | 1,817 | 8,970 | ||||||||||
Other expenses, net | (255 | ) | (1,759 | ) | (683 | ) | (933 | ) | |||||||
Equity income in net income of affiliates | 421 | 182 | 1,036 | 539 | |||||||||||
Income before income taxes | 10,884 | 8,273 | 21,285 | 12,895 | |||||||||||
Income tax benefit (expense) | 266 | 1,747 | 3,021 | (416 | ) | ||||||||||
Net income | 11,150 | 10,020 | 24,306 | 12,479 | |||||||||||
Less: Net income attributable to non-controlling interests and redeemable non-controlling interests | 995 | 1,393 | 2,114 | 2,228 | |||||||||||
Net income attributable to ACM Research, Inc. | $ | 10,155 | $ | 8,627 | $ | 22,192 | $ | 10,251 | |||||||
Comprehensive income: | |||||||||||||||
Net income | 11,150 | 10,020 | 24,306 | 12,479 | |||||||||||
Foreign currency translation adjustment | (409 | ) | 5,757 | 1,259 | 4,099 | ||||||||||
Comprehensive Income | 10,741 | 15,777 | 25,565 | 16,578 | |||||||||||
Less: Comprehensive income attributable to non-controlling interests and redeemable non-controlling interests | 757 | 2,698 | 2,471 | 3,614 | |||||||||||
Comprehensive income attributable to ACM Research, Inc. | $ | 9,984 | $ | 13,079 | $ | 23,094 | $ | 12,964 | |||||||
Net income attributable to ACM Research, Inc. per common share: | |||||||||||||||
Basic | $ | 0.52 | $ | 0.47 | $ | 1.16 | $ | 0.57 | |||||||
Diluted | $ | 0.46 | $ | 0.40 | $ | 1.02 | $ | 0.48 | |||||||
Weighted average common shares outstanding used in computing per share amounts: | |||||||||||||||
Basic | 19,422,546 | 18,201,943 | 19,113,353 | 18,124,665 | |||||||||||
Diluted | 22,042,516 | 21,555,296 | 21,730,340 | 21,257,661 | |||||||||||
ACM RESEARCH, INC. | |||||||||||||||
Total Revenue by Product Category, by Equipment Type and by Region | |||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
Total Revenue By Product Category | 2021 | 2020 | 2021 | 2020 | |||||||||||
Single Wafer Cleaning Tools (SAPS, TEBO, Tahoe) and Semi-Critical Cleaning Equipment | $ | 49,448 | $ | 38,344 | $ | 127,322 | $ | 94,468 | |||||||
ECP (front-end and packaging), Furnace and Other Technologies | 8,200 | 4,850 | 13,750 | 9,340 | |||||||||||
Advanced Packaging (excluding ECP), and Services & Spare Parts | 9,365 | 4,471 | 23,537 | 7,254 | |||||||||||
$ | 67,013 | $ | 47,665 | $ | 164,609 | $ | 111,062 | ||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
Total Revenue By Equipment Type (Front-end / Back-end) | 2021 | 2020 | 2021 | 2020 | |||||||||||
Wet cleaning and other front-end processing tools | $ | 49,448 | $ | 38,344 | $ | 127,322 | $ | 98,958 | |||||||
Advanced packaging, other processing tools, services & spares | 17,565 | 9,321 | 37,287 | 12,104 | |||||||||||
$ | 67,013 | $ | 47,665 | $ | 164,609 | $ | 111,062 | ||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
Total Revenue By Region | 2021 | 2020 | 2021 | 2020 | |||||||||||
Mainland China | $ | 66,887 | $ | 46,881 | $ | 164,319 | $ | 110,174 | |||||||
Other Regions | 126 | 784 | 290 | 888 | |||||||||||
$ | 67,013 | $ | 47,665 | $ | 164,609 | $ | 111,062 | ||||||||
ACM RESEARCH, INC.Reconciliation of GAAP to Non-GAAP Financial Measures
As described under “Use of Non-GAAP Financial Measures” above, ACM presents non-GAAP gross margin, operating expenses, operating income, net income (loss) attributable to ACM Research, Inc., and basic and diluted earnings per share as supplemental measures to GAAP financial measures, each of which excludes stock-based compensation (SBC) from the equivalent GAAP financial line items. In addition, non-GAAP net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share exclude non-cash change in fair value of financial liabilities and unrealized gain on trading securities. The following table reconciles gross margin, operating expenses, operating income, net income (loss) attributable to ACM Research, Inc., and basic and diluted earnings per share to the related non-GAAP financial measures:
Three Months Ended September 30, | ||||||||||||||||||||||||
2021 | 2020 | |||||||||||||||||||||||
Actual | SBC | Other non-operating adjustments | Adjusted | Actual | SBC | Other non-operating adjustments | Adjusted | |||||||||||||||||
(GAAP) | (Non-GAAP) | (GAAP) | (Non-GAAP) | |||||||||||||||||||||
($ in thousands) | ||||||||||||||||||||||||
Revenue | $ | 67,013 | $ | - | $ | - | $ | 67,013 | $ | 47,665 | $ | - | $ | - | $ | 47,665 | ||||||||
Cost of revenue | (37,328 | ) | (108 | ) | - | (37,220 | ) | (27,324 | ) | (44 | ) | - | (27,280 | ) | ||||||||||
Gross profit | 29,685 | (108 | ) | - | 29,793 | 20,341 | (44 | ) | - | 20,385 | ||||||||||||||
Gross margin % | 44.3 | % | 0.2 | % | 44.5 | % | 42.7 | % | 0.1 | % | 42.8 | % | ||||||||||||
Operating expenses: | ||||||||||||||||||||||||
Sales and marketing | (6,363 | ) | (417 | ) | - | (5,946 | ) | (3,924 | ) | (237 | ) | - | (3,687 | ) | ||||||||||
Research and development | (7,856 | ) | (293 | ) | - | (7,563 | ) | (4,343 | ) | (193 | ) | - | (4,150 | ) | ||||||||||
General and administrative | (3,671 | ) | (460 | ) | - | (3,211 | ) | (4,568 | ) | (2,305 | ) | - | (2,263 | ) | ||||||||||
Income from operations | $ | 11,795 | $ | (1,278 | ) | $ | - | $ | 13,073 | $ | 7,506 | $ | (2,779 | ) | $ | - | $ | 10,285 | ||||||
Operating margin % | 17.6 | % | 1.9 | % | - | 19.5 | % | 15.7 | % | 5.8 | % | - | 21.6 | % | ||||||||||
Change in fair value of financial liability | - | - | - | - | (6,533 | ) | - | (6,533 | ) | - | ||||||||||||||
Unrealized gain (loss) on trading securities | (919 | ) | - | (919 | ) | - | 8,970 | - | 8,970 | - | ||||||||||||||
Net income (loss) attributable to ACM Research, Inc. | $ | 10,155 | $ | (1,278 | ) | $ | (919 | ) | $ | 12,352 | $ | 8,627 | $ | (2,779 | ) | $ | 2,437 | $ | 8,969 | |||||
Basic EPS | $ | 0.52 | $ | 0.64 | $ | 0.47 | $ | 0.49 | ||||||||||||||||
Diluted EPS | $ | 0.46 | $ | 0.56 | $ | 0.40 | $ | 0.42 | ||||||||||||||||
Nine Months Ended September 30, | ||||||||||||||||||||||||
2021 | 2020 | |||||||||||||||||||||||
Actual | SBC | Other non-operating adjustments | Adjusted | Actual | SBC | Other non-operating adjustments | Adjusted | |||||||||||||||||
(GAAP) | (Non-GAAP) | (GAAP) | (Non-GAAP) | |||||||||||||||||||||
($ in thousands) | ||||||||||||||||||||||||
Revenue | $ | 164,609 | $ | - | $ | - | $ | 164,609 | $ | 111,062 | $ | - | $ | - | $ | 111,062 | ||||||||
Cost of revenue | (95,199 | ) | (289 | ) | - | (94,910 | ) | (61,137 | ) | (132 | ) | - | (61,005 | ) | ||||||||||
Gross profit | 69,410 | (289 | ) | - | 69,699 | 49,925 | (132 | ) | - | 50,057 | ||||||||||||||
Gross margin % | 42.2 | % | 0.2 | % | 42.3 | % | 45.0 | % | 0.1 | % | 45.1 | % | ||||||||||||
Operating expenses: | ||||||||||||||||||||||||
Sales and marketing | (17,460 | ) | (1,400 | ) | - | (16,060 | ) | (11,524 | ) | (495 | ) | - | (11,029 | ) | ||||||||||
Research and development | (21,293 | ) | (801 | ) | - | (20,492 | ) | (13,241 | ) | (568 | ) | - | (12,673 | ) | ||||||||||
General and administrative | (11,081 | ) | (1,333 | ) | - | (9,748 | ) | (9,100 | ) | (3,128 | ) | - | (5,972 | ) | ||||||||||
Income from operations | $ | 19,576 | $ | (3,823 | ) | $ | - | $ | 23,399 | $ | 16,060 | $ | (4,323 | ) | $ | - | $ | 20,383 | ||||||
Operating margin % | 11.9 | % | 2.3 | % | - | 14.2 | % | 14.5 | % | 3.9 | % | - | 18.4 | % | ||||||||||
Change in fair value of financial liability | - | - | - | - | (11,964 | ) | - | (11,964 | ) | - | ||||||||||||||
Unrealized gain on trading securities | 1,817 | - | 1,817 | - | 8,970 | - | 8,970 | - | ||||||||||||||||
Net income attributable to ACM Research, Inc. | $ | 22,192 | $ | (3,823 | ) | $ | 1,817 | $ | 24,198 | $ | 10,251 | $ | (4,323 | ) | $ | (2,994 | ) | $ | 17,568 | |||||
Basic EPS | $ | 1.16 | $ | 1.27 | $ | 0.57 | $ | 0.97 | ||||||||||||||||
Diluted EPS | $ | 1.02 | $ | 1.11 | $ | 0.48 | $ | 0.83 | ||||||||||||||||